# Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

> **NCT00826020** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 72 (actual)

## Conditions studied

- Parenteral Nutrition Associated Liver Disease PNALD
- Cholestasis

## Interventions

- **DRUG:** Omegaven™

## Key facts

- **NCT ID:** NCT00826020
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-01
- **Primary completion:** 2017-10-06
- **Final completion:** 2017-10-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00826020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00826020, "Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00826020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*